The digitalization of medical information in Europe is on the rise, with a new comprehensive report shedding light on pilot electronic Product Information (ePI) projects across 31 countries. As paper-based methods slowly give way to digital solutions, stakeholders in the pharmaceutical industry, government authorities, and healthcare professionals are witnessing a significant shift. This transformation, driven by a collaboration of AESGP, EFPIA, and Medicines for Europe, aligns closely with the revision of European pharmaceutical legislation, showing a trend towards modernizing how information is accessed by both healthcare providers and patients.
Expanding Pilots Across Europe
The ongoing ePI initiatives vary widely across participating nations, with several projects driven by cooperation with national authorities and European Commission approvals where applicable. While 14 countries actively run ePI pilots, another 7 remain in the planning stages. Meanwhile, 10 countries face barriers such as legal constraints, technical challenges, and a lack of resources, hindering their ability to initiate similar pilots.
Noteworthy Developments and Insights
Countries like the Nordic region—Finland, Denmark, Norway, Sweden, and Iceland—demonstrate notable innovation with their English-only packaging and local language ePI to improve access and logistics. Belgium and Luxembourg have shown resilience, with 97% of hospital pharmacists experiencing no inconvenience from the lack of paper leaflets after seven years. Portugal’s healthcare professionals largely support the ePI transition, enjoying easier access to information. Additionally, the Baltics—Estonia, Latvia, and Lithuania—are gaining positive feedback from pharmacists, gradually bolstering support for ePI.
– 14 countries are currently implementing ePI pilots, indicating robust participation.- 10 countries face challenges, signaling the need for streamlined support.- The Nordic region’s approach simplifies logistics and supports accessibility.- Belgium and Luxembourg’s experience shows viable paperless solutions.- The Baltics illustrate growing acceptance amongst pharmacists, enhancing the project’s credibility.
The European move towards digitalization in medicinal information is not without challenges, yet the continued collaboration can address these hurdles. Stakeholders are encouraged to learn from both positive results and faced obstacles. Real-world evidence from ongoing projects suggests that properly integrating ePI can enhance patient safety, resolve logistical issues, and promote environmental sustainability. Policymakers, healthcare professionals, and industry actors should advocate open dialogue and partnerships to support a seamless shift from paper to digital, ensuring patient interests remain at the forefront.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
